clinical trial · NCT00861068
A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).
UCB Pharma·phase2·completed·n = 44
Postherpetic NeuralgiaSPM927/LacosamidePlacebo
brief summary
The objective of the trial is to investigate the analgesic efficacy of SPM 927 in subjects with moderate to severe neuropathic pain due to Postherpetic Neuralgia (PHN)
started
Feb 1, 2002
primary completion
Dec 1, 2002
completion
Jan 1, 2003
last updated
Apr 19, 2024
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol